WA
CVS icon

WealthTrust Axiom’s CVS Health CVS Stock Holding History

WealthTrust Axiom’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$939K Sell
9,080
-30
-0.3% -$2.68K 0.21% 100
2026
Q1 		$654K Buy
9,110
+1
+0% +$77 0.16% 125
2025
Q4 		$723K Buy
9,109
+2
+0% +$158 0.19% 110
2025
Q3 		$687K Buy
9,107
+1,109
+14% +$76K 0.18% 114
2025
Q2 		$552K Sell
7,998
-2,318
-22% -$152K 0.16% 124
2025
Q1 		$699K Buy
10,316
+901
+10% +$53.9K 0.21% 95
2024
Q4 		$423K Sell
9,415
-998
-10% -$56K 0.13% 150
2024
Q3 		$655K Sell
10,413
-748
-7% -$43.6K 0.19% 108
2024
Q2 		$659K Sell
11,161
-574
-5% -$35.9K 0.22% 100
2024
Q1 		$936K Buy
11,735
+202
+2% +$15.4K 0.3% 76
2023
Q4 		$911K Buy
11,533
+1
+0% +$71 0.3% 74
2023
Q3 		$805K Sell
11,532
-999
-8% -$70.8K 0.29% 74
2023
Q2 		$866K Buy
12,531
+1
+0% +$71 0.29% 73
2023
Q1 		$931K Buy
12,530
+1
+0% +$84 0.32% 73
2022
Q4 		$1.17M Sell
12,529
-36
-0.3% -$3.47K 0.41% 58
2022
Q3 		$1.2M Sell
12,565
-46
-0.4% -$4.55K 0.46% 56
2022
Q2 		$1.17M Sell
12,611
-72
-0.6% -$7.03K 0.42% 58
2022
Q1 		$1.28M Buy
12,683
+263
+2% +$27.6K 0.4% 60
2021
Q4 		$1.28M Sell
12,420
-182
-1% -$16.8K 0.41% 59
2021
Q3 		$1.07M Sell
12,602
-707
-5% -$59.2K 0.36% 66
2021
Q2 		$1.11M Sell
13,309
-4,294
-24% -$352K 0.36% 68
2021
Q1 		$1.32M Sell
17,603
-669
-4% -$48.7K 0.45% 59
2020
Q4 		$1.25M Buy
18,272
+2,929
+19% +$191K 0.45% 55
2020
Q3 		$896K Sell
15,343
-191
-1% -$11.9K 0.39% 62
2020
Q2 		$1.01M Buy
15,534
+522
+3% +$32.9K 0.44% 55
2020
Q1 		$890K Buy
15,012
+8,662
+136% +$578K 0.44% 57
2019
Q4 		$471K Buy
6,350
+6
+0.1% +$421 0.16% 107
2019
Q3 		$400K Buy
+6,344
New +$376K 0.14% 121

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

WealthTrust Axiom's CVS Position: Q2 2026 in Review

WealthTrust Axiom reduced its CVS Health (CVS) stake by 0.33% in Q2 2026, selling an estimated $2.68K and leaving 9,080 shares worth $939K. The position accounts for 0.21% of the portfolio, ranked #100.

WealthTrust Axiom first reported a position in CVS in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.32M in Q1 2021. 2,076 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • WealthTrust Axiom held 9,080 shares of CVS Health worth $939K as of Q2 2026.
  • WealthTrust Axiom sold 30 CVS Health shares in Q2 2026, an estimated $2.68K.
  • CVS Health made up 0.21% of WealthTrust Axiom's portfolio in Q2 2026, its #100 holding.
  • WealthTrust Axiom first reported a position in CVS Health in Q3 2019 and has held it in 28 quarters since.
  • WealthTrust Axiom's CVS Health position peaked at $1.32M in Q1 2021.
  • 2,076 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on WealthTrust Axiom's 13F filing for Q2 2026, filed 11 Aug 2026.